← Back to the feed

Clee Medical SA

History from 20 Sep 2024

UID

CHE-343.543.919

Legal form

AG

Canton

GE

Founded

20 Sep 2024

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 14 Oct 2024 · legal date 20 Sep 2024

   Company formed

   Founded 20 Sep 2024

   SHAB HR01-1006153829 ↗

2. SHAB published 25 Feb 2026 · legal date 12 Feb 2026

   Capital increase

   ●●●Confirmed round

   Paid in cash and by other means

   Nominal capital

   100’000 → 152’923.28

   Shares

   11’111’110 → 15’292’328

   New shares, % of post-step shares

   27.3% (4’181’218 new)

   Share classes

   7’666’666 × CHF 0.01 · 1’111’111 × CHF 0.01 privilégiées quant au produit de liquidation · 6’514’551 × CHF 0.01

   Capital-actions: CHF 111'111.10, entièrement libéré, divisé en 7'666'666 actions de CHF 0.01, ordinaires, et 3'444'444 actions de CHF 0.01, privilégiées quant au produit de liquidation, toutes nominatives, liées selon statuts. Augmentation ordinaire du capital-actions porté de CHF 111'111.10 à CHF 152'923.28 par l'émission de 4'181'218 actions de CHF 0.01, privilégiées quant au produit de liquidation, nominatives, liées selon statuts, dont 510'585 actions libérées par compensation d'une créance d'un montant de CHF 257'335.62. Capital-actions: CHF 152'923.28, entièrement libéré, divisé en 7'666'666 actions ordinaires de CHF 0.01, 1'111'111 actions de CHF 0.01, privilégiées quant au produit …

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.72 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006580034 ↗

3. Announced 25 Feb 2026

   Round announced

   matched to a capital increase · high match confidence

   Announcement ↗

Published by 1 Mar 2026

Latest available record · 8 Oct 2026